Lack of Association Between a 3 ' UTR VNTR Polymorphism of Dopamine Transporter Gene (SLC6A3) and ADHD in a Brazilian Sample of Adult Patients

Objective: To investigate a possible association between a 3'UTR VNTR polymorphism of the dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients. Method: Study Case-control with 102 ADHD adult outpatients (DSM-IV criteria) and 479 healthy controls. The primers' sequence used were: 3'UTR-Forward: 5'TGT GGT GAT GGG AAC GGC CTG AG 3' and 3'UTR-Reverse: 5'CTT CCT GGA GGT CAC GGC TCA AGG 3'. Alleles of the 3'UTR were coded according to their number of repeats: 6- repeat 320 bp (allele 6), 8- repeat 400 bp (allele 8), 9-repeat 480 bp (allele 9), 10- repeat 480 bp (allele 10), and 11- repeat 520 bp (allele 11). Results: There were no allelic (chi(2) = 2.67, 5df, p = .75) and genotypic (chi(2) = 7.20, 1df, p = .61) association between adult ADHD and VNTR 3'UTR polymorphism of SLC6A3. Conclusion: Our findings do not support SLC6A3 as marker genetic susceptibility factor in adult ADHD. More comprehensive polymorphism coverage within the SLC6A3 region should be conducted in larger samples, including comparisons in clinical subgroups, and in samples with different ethnic backgrounds. (J. of Att. Dis. 2011; 15(4) 305-309)

Palavras-chave

association study, ADHD, case-control study, DAT1, dopamine, genetics

URI

https://observatorio.fm.usp.br/handle/OPI/23405

Referências

American Psychological Association(APA), 1994, DIAGN STAT MAN MENT
SPENCER T, 1995, ARCH GEN PSYCHIAT, V52, P434
Krause KH, 2003, NEUROSCI BIOBEHAV R, V27, P605, DOI 10.1016/j.neubiorev.2003.08.012
Schweitzer JB, 2003, NEUROPSYCHOPHARMACOL, V28, P967, DOI 10.1038/sj.npp.1300110
Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x
Faraone SV, 2000, BIOL PSYCHIAT, V48, P9, DOI 10.1016/S0006-3223(00)00889-1
Franke B, 2008, AM J MED GENET B, V147B, P1576, DOI [10.1002/ajmg.b.30861, 10.1002/ajm.b.30861]
Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5
Mill J, 2002, AM J MED GENET, V114, P975, DOI 10.1002/ajmg.10948
Faraone SV, 2004, PSYCHIAT CLIN N AM, V27, P303, DOI 10.1016/S0193-953X(03)00090-X
Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921
Cordeiro Q, 2009, REV BRAS PSIQUIATR, V31, P154, DOI 10.1590/S1516-44462009000200013
Spencer T, 2005, BIOL PSYCHIAT, V57, P456, DOI 10.1016/j.biopsych.2004.11.043
Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7
McGough JJ, 2004, AM J PSYCHIAT, V161, P1948, DOI 10.1176/appi.ajp.161.11.1948
Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132
Davidson MA, 2008, J ATTEN DISORD, V11, P628, DOI 10.1177/1087054707310878
COOK EH, 1995, AM J HUM GENET, V56, P993
Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024
Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
Cordeiro Q, 2004, ARQ NEURO-PSIQUIAT, V62, P973, DOI 10.1590/S0004-282X2004000600008
Fontana RD, 2007, ARQ NEURO-PSIQUIAT, V65, P134, DOI 10.1590/S0004-282X2007000100027
Fuke S., 2001, Pharmacogenomics Journal, V1, P152
Guardiola A, 2000, ARQ NEURO-PSIQUIAT, V58, P401, DOI 10.1590/S0004-282X2000000300001
Guindalini C, 2005, PHARMACOGENET GENOM, V15, P891
Poeta Lisiane Schilling, 2004, Revista Brasileira de Psiquiatria, V26, P150, DOI 10.1590/S1516-44462004000300004
Pondé Milena Pereira, 2007, Arq Neuropsiquiatr, V65, P240, DOI 10.1590/S0004-282X2007000200010
Silva MA, 2005, REV MED CHILE, V133, P1392, DOI 10.4067/S0034-98872005001100017
SILVA MA, 2006, ARQUIVOS NEUROPSIQUI, V64, P563
Silva Maria Aparecida da, 2009, Rev Bras Psiquiatr, V31, P390
Terwilliger JD, 2002, CURR OPIN GENET DEV, V12, P726, DOI 10.1016/S0959-437X(02)0035X
Vasconcelos MM, 2003, ARQ NEURO-PSIQUIAT, V61, P67, DOI 10.1590/S0004-282X2003000100012

Coleções

Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23

Página do item completo